Consonance Capital

Consonance Capital Management as of Dec. 31, 2016

Portfolio Holdings for Consonance Capital Management

Consonance Capital Management holds 23 positions in its portfolio as reported in the December 2016 quarterly 13F filing

Company (Ticker) Portfolio Weight Valued At Change in Shares Share Count Share Price
Clovis Oncology 13.3 $121M 2.7M 44.42
Horizon Pharma 10.3 $94M 5.8M 16.18
United Therapeutics Corporation (UTHR) 9.2 $83M 581k 143.43
Amarin Corporation (AMRN) 8.5 $77M 25M 3.08
Mallinckrodt Pub 6.3 $58M 1.2M 49.82
Retrophin 5.8 $53M 2.8M 18.93
AtriCure (ATRC) 5.7 $52M 2.7M 19.57
Globus Med Inc cl a (GMED) 5.1 $46M 1.9M 24.82
Ariad Pharmaceuticals 4.9 $44M 3.6M 12.44
Mednax (MD) 4.8 $44M 660k 66.66
Myriad Genetics (MYGN) 4.3 $39M 2.3M 16.67
Merrimack Pharmaceuticals In 4.1 $37M 9.1M 4.08
AMAG Pharmaceuticals 3.9 $36M 1.0M 34.80
Biosante Pharmaceuticals (ANIP) 3.3 $30M 492k 60.62
Array BioPharma 2.6 $24M 2.7M 8.78
Pacira Pharmaceuticals (PCRX) 2.2 $20M 632k 32.30
Novadaq Technologies 1.9 $17M 2.4M 7.09
Acadia Healthcare (ACHC) 1.9 $17M 511k 33.10
Vericel (VCEL) 1.0 $8.9M 3.0M 3.00
Adma Biologics (ADMA) 0.7 $6.5M 1.3M 5.12
Biolase Technology 0.2 $2.0M 1.4M 1.40
Seaspine Holdings 0.1 $1.0M 128k 7.90
Veracyte (VCYT) 0.0 $362k 47k 7.74